Search
for
Sort by
Research 121–150 of 1000+
- Phenotypic profiling of parents with cryptic nonclassic congenital adrenal hyperplasia: findings in 145 unrelated families
- 3 alpha, 17 beta-androstanediol glucuronide in plasma. A marker of androgen action in idiopathic hirsutism.
- Comparison of Complications after Coronavirus Disease and Seasonal Influenza, South Korea
- New Insight for Enhanced Topical Targeting of Caffeine for Effective Cellulite Treatment: In Vitro Characterization, Permeation Studies, and Histological Evaluation in Rats
- The effects of topical diazoxide on hair follicular growth and physiology of the stumptailed macaque
- Combination Therapies and the Theoretical Limits of Evidence-Based Medicine
- The Hirsute Woman: Challenges in Evaluation and Management
- Androgen Dependence of Hirsutism, Acne, and Alopecia in Women
- Idiopathic hirsutism: excessive bodily and facial hair in women
- Mucocutaneous reactions to chemotherapy
- Study on Histamine Related Enzyme Activities during Murine Hair Cycle.
- Follikelhormone
- Holistic management plan for polycystic ovarian syndrome (PCOS): A systematic literature review
- Toll-like receptor 4 (TLR4): new insight immune and aging
- Ovarian Hilus-Cell Hyperplasia and High Serum Testosterone in a Patient With Postmenopausal Virilization
- NDA Submission of Vepdegestrant (ARV-471) to U.S. FDA: The Beginning of a New Era of PROTAC Degraders
- Effects of chronic inhibition of Testosterone metabolism on cardiac remodeling after ischemia/reperfusion-induced myocardial damage in gonadectomized rats
- Pre-receptor regulation of the androgen receptor
- Activity of type 1 5α-reductase is greater in the follicular infrainfundibulum compared with the epidermis
- Molecular interactions of progesterone derivatives with 5α-reductase types 1 and 2 and androgen receptors
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
- Curcumin derivatives inhibit testicular 17β-hydroxysteroid dehydrogenase 3
- Androgenic and anti-androgenic effects of progesterone derivatives with different halogens as substituents at the C-6 position
- Effect of C-ring modifications in benzo[c]quinolizin-3-ones, new selective inhibitors of human 5α-reductase 1
- The 5alpha-reductase type 1, but not type 2, gene is expressed in anagen hairs plucked from the vertex area of the scalp of hirsute women and normal individuals
- PCOS-Management of Androgenetic Alopecia
- 11α-Hydroxyprogesterone, a potent 11β-hydroxysteroid dehydrogenase inhibitor, is metabolised by steroid-5α-reductase and cytochrome P450 17α-hydroxylase/17,20-lyase to produce C11α-derivatives of 21-deoxycortisol and 11-hydroxyandrostenedione in vitro
- Benzo[<i>c</i>]quinolizin-3-ones: A Novel Class of Potent and Selective Nonsteroidal Inhibitors of Human Steroid 5α-Reductase 1
- Topische Immuntherapie mit Diphenylcyclopropenon bei verschiedenen Typen der Alpecia areata: Assoziation zu klinischen Parametern und einem funktionellen Genpolymorphismus des Interleukin-6-Promotors
- A preliminary study on the relationship between environmental endocrine disruptors and precocious puberty in girls